Which has grown faster, MDXG or SOPH?

Over the past five years, SOPH grew revenue faster — MDXG at a 6.36% CAGR versus SOPH at 20.33%.

Is MDXG or SOPH more profitable?

MDXG runs the higher net margin — MDXG at 1.76% versus SOPH at -93.86%.

How have MDXG and SOPH total returns compared?

Over the past 5 years, MDXG delivered -4.94% and SOPH delivered -13.62% annualized total return. Past performance doesn't predict future results.

MiMedx Group, Inc. (MDXG) vs SOPHiA GENETICS S.A. (SOPH)

A side-by-side comparison of MiMedx Group, Inc. and SOPHiA GENETICS S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MDXG

MiMedx Group, Inc.

$663M

$4.55HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT

SOPH

SOPHiA GENETICS S.A.

$626M

$7.46HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — MDXG vs SOPH

growth of $100 · dividends reinvested · last 5y

MDXG -61.5% (-17.4%/yr)SOPH -51.1% (-13.3%/yr)SOPH compounded faster over this window

MDXG SOPH

MDXG vs SOPH: by the numbers

•MDXG is the larger company ($663M vs $626M market cap).
•MDXG is profitable (1.76% net margin) while SOPH runs a net loss (-93.86%).
•SOPH grew revenue faster over the past five years (20.33% vs 6.36% CAGR).

Metrics side by side

Valuation

Metric	MDXG	SOPH
P/E ratio	113.70	N/A
P/S ratio	1.87	7.26
P/B ratio	3.07	7.53
EV / EBITDA	25.90	N/A
FCF yield	6.12%	N/A

Profitability

Metric	MDXG	SOPH
Gross margin	78.85%	66.63%
Operating margin	15.26%	-85.01%
Net margin	1.76%	-93.86%
ROE	2.89%	-97.31%
ROIC	1.97%	-49.73%

Growth (annualized)

Metric	MDXG	SOPH
Revenue CAGR (5Y)	6.36%	20.33%
Total return CAGR (5Y)	-4.94%	-13.62%

Frequently asked

Which has grown faster, MDXG or SOPH?: Over the past five years, SOPH grew revenue faster — MDXG at a 6.36% CAGR versus SOPH at 20.33%.
Is MDXG or SOPH more profitable?: MDXG runs the higher net margin — MDXG at 1.76% versus SOPH at -93.86%.
How have MDXG and SOPH total returns compared?: Over the past 5 years, MDXG delivered -4.94% and SOPH delivered -13.62% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MDXG analysis Full SOPH analysis Interactive comparison tool

Dig into the metrics

MiMedx P/E ratio MiMedx ROE SOPHiA GENETICS ROE MiMedx operating margin SOPHiA GENETICS operating margin MiMedx revenue growth SOPHiA GENETICS revenue growth MiMedx free cash flow SOPHiA GENETICS free cash flow

MiMedx & SOPHiA GENETICS appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.